These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14593189)

  • 21. Analysis of the effect of breast magnetic resonance imaging on the outcome in women undergoing breast conservation surgery with radiation therapy.
    Ko ES; Han BK; Kim RB; Ko EY; Shin JH; Nam SY; Nam M; Nam SJ; Lee JE; Kil WH; Lee SK
    J Surg Oncol; 2013 Jun; 107(8):815-21. PubMed ID: 23505028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.
    Kim JY; Cho N; Koo HR; Yi A; Kim WH; Lee SH; Chang JM; Han W; Moon HG; Im SA; Noh DY; Moon WK
    Radiology; 2013 Apr; 267(1):57-66. PubMed ID: 23329656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
    Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
    Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.
    Pediconi F; Miglio E; Telesca M; Luciani ML; Kirchin MA; Passariello R; Catalano C
    Invest Radiol; 2012 Feb; 47(2):128-35. PubMed ID: 21934515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of the breast after surgery for breast cancer.
    Whitehouse GH; Moore NR
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.
    Fischer U; Kopka L; Grabbe E
    Radiology; 1999 Dec; 213(3):881-8. PubMed ID: 10580970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
    Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
    Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection criteria for expander/implant breast reconstruction following radiation therapy.
    Parsa AA; Jackowe DJ; Johnson EW; Lye KD; Iwahira Y; Huynh TV; Pedro P; Pang J; Parsa FD
    Hawaii Med J; 2009 Apr; 68(3):66-8. PubMed ID: 19441617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
    Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
    AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of breast MRI in the preoperative evaluation of patients with newly diagnosed breast cancer.
    Schell AM; Rosenkranz K; Lewis PJ
    AJR Am J Roentgenol; 2009 May; 192(5):1438-44. PubMed ID: 19380574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation therapy of cancer in prosthetically augmented or reconstructed breasts.
    Chu FC; Kaufmann TP; Dawson GA; Kim YS; Rajaratnam S; Hoffman LA
    Radiology; 1992 Nov; 185(2):429-33. PubMed ID: 1410349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
    Partridge SC; Gibbs JE; Lu Y; Esserman LJ; Sudilovsky D; Hylton NM
    AJR Am J Roentgenol; 2002 Nov; 179(5):1193-9. PubMed ID: 12388497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of breast cancer extent and enhancement patterns using 3D-dynamic MR imaging: correlation with intraductal component].
    Shiraishi A; Suzuki M; Nozu S; Suzuki H; Kurosumi M; Katayama H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Mar; 59(4):122-30. PubMed ID: 10349310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.